This case reports on a 53-year-old male patient with primary refractory high-grade B-cell lymphoma, who was hospitalized to undergo Chimeric Antigen Receptor (CAR) T-cell therapy. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_33_2021_E_web_compressed.pdf"]
Lee mas